| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207875A1 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 05/29/2002 | EP1207872A1 Ibuprofen-containing softgels |
| 05/29/2002 | EP1207868A1 Pharmaceutical tramadol salts |
| 05/29/2002 | EP1207867A1 Oral pharmaceutical forms of administration with a delayed action |
| 05/29/2002 | EP1207866A1 Delayed-action form of administration containing tramadol saccharinate |
| 05/29/2002 | EP1207861A1 Treatment of fungal infections utilizing a fungal growth medium |
| 05/29/2002 | EP1207860A1 Controlled release pellet formulation |
| 05/29/2002 | EP1207859A1 Oral form of administration containing probiotic micro-organisms |
| 05/29/2002 | EP1207858A1 Oral dosage forms |
| 05/29/2002 | EP1207857A1 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
| 05/29/2002 | EP1207856A2 Coformulation methods and their products |
| 05/29/2002 | EP1207853A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 05/29/2002 | EP1207852A1 Controlled release oral dosage suitable for oral administration |
| 05/29/2002 | EP1207851A1 Topical organic ectoparasiticidal formulations |
| 05/29/2002 | EP1207843A2 Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
| 05/29/2002 | EP1207811A1 Nitric oxide releasing medical devices |
| 05/29/2002 | EP1207757A1 Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 05/29/2002 | EP1207754A1 Medicinal composition and its process of preparation |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0923382B1 Compositions of plant carbohydrates as dietary supplements |
| 05/29/2002 | EP0774974B1 Nucleic acid vaccine |
| 05/29/2002 | DE10059053A1 Anticoagulant composition containing anticoagulant in acidic solution or suspension useful e.g. for treatment of thrombosis and for promotion of wound healing |
| 05/29/2002 | DE10059020A1 Parenteral applizierbare Darreichungsformen Dosage forms can be administered parenterally |
| 05/29/2002 | DE10055742A1 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/29/2002 | CN1351612A Novel organic anion transport proteins |
| 05/29/2002 | CN1351499A Composition pharmaceutique |
| 05/29/2002 | CN1351495A Liposome compositions for improved drugretention |
| 05/29/2002 | CN1351494A Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/29/2002 | CN1351489A Granules containing a plant substance and method for producing the same |
| 05/29/2002 | CN1351473A Composition |
| 05/29/2002 | CN1351010A Multi-core style carotenoid granules |
| 05/29/2002 | CN1350841A Terpene ethoxylate as solubilizer used in extracts in cosmetic or medical or food preparations |
| 05/29/2002 | CN1085690C Polyethylene oxides having saccharide residue at one end and different functional group at another end, and process for producing the same |
| 05/29/2002 | CN1085689C Water soluble active sulfones of poly(ethylene glycoL) and relative polymer for modifying surface and molecule of substances |
| 05/29/2002 | CN1085687C Polymeric matrices and their uses in pharmaceutial compositions |
| 05/29/2002 | CN1085526C Air pressed package using polyoxyethylene glyceryl oleate |
| 05/29/2002 | CN1085525C Air pressed package using polyoxyethyene glyceryl oleate |
| 05/29/2002 | CN1085523C Preparation of epidermis and process for its preparation |
| 05/28/2002 | US6395875 A polypeptide that binds the d1 domain of the human coxsackie virus; for screening viricidial agents; therapy for respiratory and gastrointestinal infections |
| 05/28/2002 | US6395867 Polymers with thiol terminal function |
| 05/28/2002 | US6395788 Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
| 05/28/2002 | US6395756 Use of ophthalmic agent |
| 05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
| 05/28/2002 | US6395721 Low potency unpreserved sterile topical corticosteroid compositions for dermatitis |
| 05/28/2002 | US6395713 Cationic lipidcationic lipid |
| 05/28/2002 | US6395513 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/28/2002 | US6395494 Method to determine TGF-β |
| 05/28/2002 | US6395313 Ngali nut oil |
| 05/28/2002 | US6395304 Apparatus and method for preparing microparticles |
| 05/28/2002 | US6395302 Method for the preparation of microspheres which contain colloidal systems |
| 05/28/2002 | US6395299 Matrices for drug delivery and methods for making and using the same |
| 05/28/2002 | US6395298 Gellan gum tablet coating |
| 05/28/2002 | US6395293 Biodegradable implant precursor |
| 05/28/2002 | US6395288 Fibrin sealant |
| 05/28/2002 | US6395287 Maxacalcitol as an active ingredient and polyethylene glycol, cetyl ether as nonionic surfactant |
| 05/28/2002 | US6395284 Mesomorphic complex of vitamin a acid and polyethyleneimine or poly-l-amino acid; treatment of skin disorders such as acne; antitumor agents |
| 05/28/2002 | US6395280 Deodorant agents for oral use for discharges and method for relieving odor of discharges |
| 05/28/2002 | US6395276 Killing malignant b cells by contacting with protein having ribonuclease activity linked to antibody against b cell surface marker; anticancer agents |
| 05/28/2002 | US6395270 Activated protein C formulations |
| 05/28/2002 | US6395266 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 05/28/2002 | US6395262 Improving transfer resistance by using copolymer of monoolefinically unsaturated c3-c6 carboxylic monomer and anhydride and a fatty-chain monomeric ester of acrylic acid; lipsticks |
| 05/28/2002 | US6395254 Diagnosis of tumors and inflammatory disease |
| 05/28/2002 | US6395029 Sustained delivery of polyionic bioactive agents |
| 05/28/2002 | CA2325014C 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions |
| 05/28/2002 | CA2248006C Activated linkers and methods for making and purifying the same |
| 05/28/2002 | CA2129855C Pressurized gas packagings using polyoxyethylene glyceryl-oleates |
| 05/28/2002 | CA2090104C Stabilized retinoid-containing skin care compositions |
| 05/28/2002 | CA2050971C Liposomal delivery system with photoactivatable triggered release |
| 05/28/2002 | CA2048300C Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
| 05/23/2002 | WO2002040545A2 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040536A2 Acylated antimicrobial peptides |
| 05/23/2002 | WO2002040510A2 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
| 05/23/2002 | WO2002040488A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy |
| 05/23/2002 | WO2002040242A1 Electroprocessed collagen |
| 05/23/2002 | WO2002040062A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | WO2002040058A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 05/23/2002 | WO2002040057A1 Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions |
| 05/23/2002 | WO2002040056A2 Carrageenan viscoelastics for ocular surgery |
| 05/23/2002 | WO2002040055A2 Solutions and films of glycated chitosan |
| 05/23/2002 | WO2002040054A1 Pharmaceutical preparation containing copolyvidone |
| 05/23/2002 | WO2002040053A1 Pharmaceutical preparation containing talc/barium sulfate |
| 05/23/2002 | WO2002040045A2 Microspheres of pancreatic enzymes with high stability |
| 05/23/2002 | WO2002040040A1 Camptothecin compounds with a sulfhydryl group |
| 05/23/2002 | WO2002040039A2 In vivo use of water absorbent polymers |
| 05/23/2002 | WO2002040034A1 Complexes of phosphate derivatives |
| 05/23/2002 | WO2002040033A1 Formulation containing phosphate derivatives of electron transfer agents |
| 05/23/2002 | WO2002040029A2 Corticosteroids adducts with natural polysaccharide polymers |
| 05/23/2002 | WO2002040011A1 Process for producing drug granules containing branched amino acids |
| 05/23/2002 | WO2002040004A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | WO2002040003A1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 05/23/2002 | WO2002039993A2 Pharmaceutival preparations comprising corticosteroids and antiinfective agents |
| 05/23/2002 | WO2002039992A2 Adducts of quinolonic agents with natural polysaccharide polymers |
| 05/23/2002 | WO2002039986A1 Process for producing microparticles |
| 05/23/2002 | WO2002039985A1 Parenterally administrable microparticles |
| 05/23/2002 | WO2002039984A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 05/23/2002 | WO2002039983A2 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 05/23/2002 | WO2002039981A1 Microgranules based on active principle and method for making same |
| 05/23/2002 | WO2002039980A2 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole |